These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21112155)

  • 21. Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.
    Scott LJ; Figgitt DP; Keam SJ; Waugh J
    CNS Drugs; 2005; 19(5):445-64. PubMed ID: 15907154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized placebo-controlled trial of gabapentin for cocaine dependence.
    Bisaga A; Aharonovich E; Garawi F; Levin FR; Rubin E; Raby WN; Nunes EV
    Drug Alcohol Depend; 2006 Feb; 81(3):267-74. PubMed ID: 16169160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acamprosate and its efficacy in treating alcohol dependent adolescents.
    Niederhofer H; Staffen W
    Eur Child Adolesc Psychiatry; 2003 Jun; 12(3):144-8. PubMed ID: 12768462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data.
    Mason BJ; Lehert P
    Alcohol Clin Exp Res; 2012 Mar; 36(3):497-508. PubMed ID: 21895717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials.
    Kranzler HR; Gage A
    Am J Addict; 2008; 17(1):70-6. PubMed ID: 18214726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olanzapine in cocaine dependence: a double-blind, placebo-controlled trial.
    Hamilton JD; Nguyen QX; Gerber RM; Rubio NB
    Am J Addict; 2009; 18(1):48-52. PubMed ID: 19219665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.
    Rubio G; Jiménez-Arriero MA; Ponce G; Palomo T
    Alcohol Alcohol; 2001; 36(5):419-25. PubMed ID: 11524308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot trial of olanzapine for the treatment of cocaine dependence.
    Kampman KM; Pettinati H; Lynch KG; Sparkman T; O'Brien CP
    Drug Alcohol Depend; 2003 Jun; 70(3):265-73. PubMed ID: 12757964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence.
    Whitworth AB; Fischer F; Lesch OM; Nimmerrichter A; Oberbauer H; Platz T; Potgieter A; Walter H; Fleischhacker WW
    Lancet; 1996 May; 347(9013):1438-42. PubMed ID: 8676626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot trial of topiramate for the treatment of cocaine dependence.
    Kampman KM; Pettinati H; Lynch KG; Dackis C; Sparkman T; Weigley C; O'Brien CP
    Drug Alcohol Depend; 2004 Sep; 75(3):233-40. PubMed ID: 15283944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acamprosate for alcohol dependence.
    Rösner S; Hackl-Herrwerth A; Leucht S; Lehert P; Vecchi S; Soyka M
    Cochrane Database Syst Rev; 2010 Sep; (9):CD004332. PubMed ID: 20824837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study.
    Pelc I; Verbanck P; Le Bon O; Gavrilovic M; Lion K; Lehert P
    Br J Psychiatry; 1997 Jul; 171():73-7. PubMed ID: 9328500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varenicline for the Treatment of Cocaine Dependence.
    Lynch KG; Plebani J; Spratt K; Morales M; Tamminga M; Feibush P; Kampman KM
    J Addict Med; 2022 Mar-Apr 01; 16(2):157-163. PubMed ID: 33840773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment.
    Schottenfeld RS; Chawarski MC; Cubells JF; George TP; Lappalainen J; Kosten TR
    Drug Alcohol Depend; 2014 Mar; 136():36-42. PubMed ID: 24462581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of acamprosate for the treatment of alcohol dependence long after recovery from withdrawal syndrome: a randomized, double-blind, placebo-controlled study conducted in Japan (Sunrise Study).
    Higuchi S;
    J Clin Psychiatry; 2015 Feb; 76(2):181-8. PubMed ID: 25742205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study.
    Besson J; Aeby F; Kasas A; Lehert P; Potgieter A
    Alcohol Clin Exp Res; 1998 May; 22(3):573-9. PubMed ID: 9622434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence.
    Pettinati HM; Kampman KM; Lynch KG; Xie H; Dackis C; Rabinowitz AR; O'Brien CP
    Addict Behav; 2008 May; 33(5):651-67. PubMed ID: 18079068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees.
    Brodie JD; Case BG; Figueroa E; Dewey SL; Robinson JA; Wanderling JA; Laska EM
    Am J Psychiatry; 2009 Nov; 166(11):1269-77. PubMed ID: 19651710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective.
    Soyka M; Chick J
    Am J Addict; 2003; 12(s1):s69-s80. PubMed ID: 14972781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.